Jul 28, 2026 02:36AM
Jul 27, 2026 07:02AM
Jul 27, 2026 07:00AM
Jun 26, 2026 06:41AM
May 18, 2026 07:06AM
May 18, 2026 07:05AM
May 18, 2026 07:00AM Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update
Mar 23, 2026 03:12AM
Mar 17, 2026 04:01PM
Feb 24, 2026 04:34AM
Feb 24, 2026 12:43AM
Feb 23, 2026 08:00AM
Feb 23, 2026 08:00AM
Nov 13, 2025 07:29AM Gossamer Bio's (GOSS) Seralitinib Data Likely Comes Out by Feb - Cantor Fitzgerald
Sep 25, 2025 07:41AM
Sep 25, 2025 07:41AM
Sep 25, 2025 07:31AM
Sep 25, 2025 07:31AM
May 15, 2025 04:01PM
Oct 31, 2024 07:00AM
Mar 12, 2024 07:32AM Gossamer Bio (GOSS) Appoints Steven D. Nathan and Skye Drynan to its Board
Mar 12, 2024 07:31AM
May 18, 2023 07:05AM
May 9, 2023 04:01PM
Apr 3, 2023 04:04PM
Mar 17, 2023 07:31AM
Apr 25, 2022 08:54AM
Mar 3, 2022 04:01PM Gossamer Bio Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Business Update
Mar 5, 2021 06:23PM
Feb 25, 2021 07:31AM
Dec 7, 2020 07:03AM
Oct 13, 2020 07:05AM
Oct 13, 2020 07:04AM
Sep 1, 2020 04:30PM
May 27, 2020 04:36PM Aerpio Pharma (ARPO), Quantum Leap Healthcare Collaborative Announce Selection of Razuprotafib for Evaluation in I-SPY COVID Trial for Treatment of ARDS in COVID-19 Patients
May 27, 2020 04:30PM
May 27, 2020 04:30PM
May 12, 2020 04:01PM
Nov 12, 2019 04:05PM
Nov 12, 2019 07:13AM
Nov 12, 2019 07:00AM
May 14, 2019 06:00AM Gossamer Bio Announces First Quarter 2019 Financial Results

327,504 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All